The roles of gender, the menopause and hormone replacement on cardiovascular function

Cardiovascular Research

Volumn 46, Issue 1, 2000, Pages 28-49

  Hayward, Christopher S ^a,b   Kelly, Raymond P ^b   Collins, Peter ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Epidemiology; Gender; Hormones

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TESTOSTERONE;

CARDIOVASCULAR DISEASE; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT;

AGING; ANIMALS; CARDIOMEGALY; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART VENTRICLES; HORMONE REPLACEMENT THERAPY; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, INBRED STRAINS; SEX; TESTOSTERONE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034061694     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00005-5     Document Type: Review

References (256)

1. Kannel W.B., Wilson P.W.F. Risk factors that attenuate the female coronary disease advantage. Arch Int Med. 155:1995;57-61.
2. Wenger N.K., Speroff L., Packard B. Cardiovascular health and disease in women. N Engl J Med. 329:1993;247-256.
3. Wenger N.K. Women's heart research: it's about time. J Women Health. 4:1995;459-460.
4. Dittrich H., Gilpin E., Nicod P., et al. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol. 62:1988;1-7.
5. Greenland P., Reicher-Reiss H., Goldbourt U., Behar S. In-hospital and 1-year mortality in 1524 women after myocardial infarction. Comparison with 4315 men. Circulation. 83:1991;484-491.
6. Shapira I., Isakov A., Burke M., Almog C. Cardiac rupture in patients with acute myocardial infarction. Chest. 92:1987;219-223.
7. Vaccarino V., Krumholz H.M., Berkman L.F., Horwitz R.I. Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation. 91:1995;1861-1871.
8. Kostis J.B., Wlison A.C., O'Dowd K., et al. Sex differences in the management and long-term outcome of acute myocardial infarction. A state-wide study. Myocardial Infarction Data Acquisition System. Circulation. 90:1994;1715-1730.
9. Bueno H., Vidan T., Almazan A., Lopez-Sendon J.L., Delcan J.L. Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction. Circulation. 92:1995;1133-1140.
10. Greenberg M.A., Mueller H.S. Why the excess mortality in women after PTCA? Circulation. 87:1993;1030-1032.
11. Bell M.R., Holmes D.R., Berger P.B., et al. The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty. J Am Med Assoc. 269:1993;2091-2095.
12. Kelsey S.F., James M., Holubkov A.L., et al. Results of percutaneous transluminal coronary angioplasty in women. 1985-6 NHLBI Coronary Angioplasty Registry. Circulation. 87:1993;720-727.
13. Acinapura A.J., Cane J., Robertazzi R.R., et al. The relationship of gender to cardiac surgery mortality: is female gender alone an operative risk factor. Circulation. 96:(8):1997;1-371. Abstract.
14. Khan S.S., Nessim S., Gray R., Czer L.S., Chaux A., Matloff J. Increased mortality of women in coronary artery bypass surgery: evidence for a referral bias. Ann Intern Med. 112:1990;561-567.
15. O'Connor G.T., Morton J.R., Diehl M.J., et al. Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation. 88:1993;2104-2110.
16. Adams J.N., Jamieson M., Rawles J.M., Trent R.J., Jennings K.P. Women and myocardial infarction: agism rather than sexism. Br Heart J. 73:1995;87-91.
17. Kudenchuk P.J., Maynard C., Martin J.S., et al., Wirkus M., Weaver W.D. MITI Project of presentation, treatment, and outcome of acute myocardial infarction in men versus women (The Myocardial Infarction Triage and Intervention Registry). Am J Cardiol. 78:1996;9-14.
18. Wenger N.K. Gender, coronary artery disease and coronary bypass surgery. Ann Intern Med. 112:1990;557-558.
19. Demirovic J., Blackburn H., McGovern P.G., et al. Sex differences in early mortality after acute myocardial infarction (The Minnesota Heart Survey). Am J Cardiol. 75:1995;1096-1101.
20. Kimmelstiel C.D., Konstam M.A. Heart failure in women. Cardiology. 86:1995;304-309.
21. Batts K.P., Ackermann D.M., Edwards W.D. Postinfarction rupture of the left ventricular free wall: Clinicopathologic correlates in 100 consecutive autopsy cases. Hum Pathol. 21:1990;530-535.
22. Becker R.C., Gore J.M., Lambrew C., et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol. 27:1996;1321-1326.
23. Shub C., Klein A.L., Zachariah P.K., Basey K.R., Tajik A.J. Determination of left ventricular mass by echocardiography in a normal population: Effect of age and sex in addition to body size. Mayo Clin Proc. 69:1994;205-211.
24. Carroll J.D., Carroll E.P., Feldman T., et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 86:1992;1099-1107.
25. Krumholz H.M., Larson M., Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol. 72:(3):1993;310-313.
26. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
27. Ganau A., Devereaux R.B., Roman M.J., et al. Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension. J Am Coll Cardiol. 19:1992;1550-1558.
28. Krumholz H.M., Larson M., Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 25:(4):1995;879-884.
29. Devereux R.B., de Simone G., Pickering T.G., Schwartz J.E., Roman M.J. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension. 31:(4):1998;929-936.
30. Lauer M.S., Anderson K.M., Larson M.G., Levy D. A new method for indexing left ventricular mass for differences in body size. Am J Cardiol. 74:1994;487-491.
31. Vasan R.S., Larson M.G., Levy D., Evans J.C., Benjamin E.J. Distribution and categorization of echocardiographic measurements in relation to reference limits. The Framingham Heart Study: Formulation of a height- and sex-specific classification and its prospective validation. Circulation. 96:1997;1863-1873.
32. Devereux R.B., Lutas E.M., Casale P.N., et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 4:1984;1222-1230.
33. Verdecchia P., Schillaci G., Borgioni C., et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 25:(4):1995;871-878.
34. Gardin J.M., Henry W.L., Savage D.D., Ware J.H., Burn C., Borer J.S. Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease. J Clin Ultrasound. 7:1979;439-447.
35. Batterham A.M., George K.P., Mullineaux D.R. Allometric scaling of left ventricular mass by body dimensions in males and females. Med Sci Sports Exerc. 29:(2):1997;181-186.
36. Dannenberg A.L., Levy D., Garrison R.J. Impact of age on echocardiographic left ventricular mass in a healthy population (The Framingham Study). Am J Cardiol. 64:1989;1066-1068.
37. Marcus R, Krause L, Weder AB, Dominguez-Mejia, Schork NJ, Julius S. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994;90:928-936.
38. Olivetti G., Giorgano G., Corradi D., et al. Gender differences and ageing: effects on the human heart. J Am Coll Cardiol. 26:1995;1068-1079.
39. de Simone G., Devereux R.B., Kimball T.R., et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension. 31:(5):1998;1077-1082.
40. Verdecchia P., Schillaci G., Boldrini F., Guerreri M., Porcellati C. Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension. J Hypertens. 10:1992;683-692.
41. de Simone G., Devereaux R.B., Roman M.J., Alderman M.H., Laragh J.H. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 23:1994;600-606.
42. Chen C.-H., Ting C.-T., Lin S.-L., et al. Which arterial and cardiac parameters best predict left ventricular mass? Circulation. 98:1998;422-428.
43. Devereux R.B., Roman M.J., de Simone G., et al. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians. The Strong Heart Study. Circulation. 96:1997;1416-1423.
44. Levy D., Anderson K.M., Savage D.D., et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. Ann Int Med. 108:1988;7-13.
45. Devereux R.B. Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization, and comparison to other methods. Hypertension. 9:(Suppl 2):1987;1136-1139.
46. Devereux R.B., Pickering T.G., Alderman M.H., et al. Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables. Hypertension. 9:(Suppl 2):1987;1153-1160.
47. Aurigemma G.P., Silver K.H., McLaughlin M., Mauser J., Gaasch W.H. Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol. 74:1994;794-798.
48. de Simone G., Devereux R.B., Roman M.J., et al. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults. Am J Cardiol. 68:1991;1704-1708.
49. Topol E.J., Traill T.A., Fortuin N.J. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med. 312:1985;277-283.
50. Pearson A.C., Gudipati C.V., Labovitz A. Systolic and diastolic flow abnormalities in elderly patients with hypertensive hypertrophic cardiomyopathy. J Am Coll Cardiol. 12:1988;989-995.
51. Lewis J.F., Maron B.J. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol. 13:1989;36-45.
52. Teare D. Asymmetric hypertrophy of the heart in young adults. Br Heart J. 20:1958;1-8.
53. Domanski M.J., Davis B.R., Pfeffer M.A., Kastantin M., Mitchell G.F. Isolated systolic hypertension: prognostic information provided by pulse pressure. Hypertension. 34:(3):1999;375-380.
54. Villari B., Campbell S.E., Schneider J., Vassalli G., Chiarello M., Hess O.M. Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J. 16:1995;1410-1419.
55. Buonanno C., Arbustini E., Rossi L., et al. Left ventricular function in men and women. Another difference between sexes. Eur Heart J. 3:(6):1982;525-528.
56. Bommer W.J., Shamanski L., Fried L., et al. Left ventricular systolic function in the cardiovascular health study. Circulation. 92:(I):1995;335-336. Abstract.
57. Bogaert J., Marchal G., Herregods M.-C., Van de Werf F., Rademakers F.E. Gender-related differences in myocardial function and morphology. Circulation. 94:1996;1-421. Abstract.
58. Hayward CS. The effect of age and gender on ventriculo-vascular coupling in humans. Doctor of Medicine Thesis. Sydney: University of New South Wales, 1998, 323 p.
59. Mendelson M.A., Hendel R.C. Myocardial infarction in women. Cardiology. 86:1995;272-285.
60. Lindenfeld J., Krause-Steinrauf H., Salerno J. Where are all the women with heart failure? J Am Coll Cardiol. 30:(6):1997;1417-1419.
61. Mosterd A., Hoes A.W., de Bruyne M.C., et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J. 20:(6):1999;447-455.
62. Schocken D.D., Arrieta M.I., Leaverton P.E., Ross E.A. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 20:1992;301-306.
63. Adams K.F., Dunlap S.H., Sueta C.A., et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol. 28:1996;1781-1788.
64. Adams K.F. Jr., Sueta C.A., Gheorghiade M., et al. Gender differences in survival in advanced heart failure: Insights from the FIRST study. Circulation. 99:(14):1999;1816-1821.
65. Tofler G.H., Stone P.H., Muller J.E., et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, especially black women. J Am Coll Cardiol. 9:1987;473-482.
66. Mendes L.A., Davidoff R., Cupples L.A., Ryan T.J., Jacobs A.K. Congestive heart failure in patients with coronary artery disease: the gender paradox. Am Heart J. 134:(2 Pt 1):1997;207-212.
67. Hoffman R.M., Psaty B.M., Kronmal R.A. Modifiable risk factors for incident heart failure in the Coronary Artery Surgery Study. Arch Intern Med. 154:1994;417-423.
68. Davis K.B., Chaitman B., Ryan T., Bittner V., Kennedy J.W. Comparison of 15 year survival for men and women after initial medical or surgical treatment for coronary artery disease; a CASS registry study. J Am Coll Cardiol. 25:1995;1000-1009.
69. Becker R.C. Coronary thrombolysis in the treatment of women with acute myocardial infarction. Cardiology. 86:1995;299-303.
70. Vasan R.S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 33:(7):1999;1948-1955.
71. Benjamin E.J., Levy D., Anderson K.M., et al. Determinants of doppler indexes of left ventricular diastolic function in normal subjects (The Framingham Heart Study). Am J Cardiol. 70:1992;508-515.
72. Spirito P., Maron B.J. Influence of ageing on doppler echocardiographic indices of left ventricular diastolic function. Br Heart J. 59:1988;672-679.
73. Voutilainen S., Kupari M., Hippelainen M., et al. Factors influencing doppler indexes of left ventricular filling in healthy persons. Am J Cardiol. 68:1991;653-659.
74. Capasso J.M., Remily R.M., Smith R.H., Sonnenblick E.H. Sex differences in the myocardial contractility in the rat. Basic Res Cardiol. 78:1983;156-171.
75. 2+. Eur J Pharmacol. 361:(1):1998;73-77.
76. Schaible T.F., Scheuer J. Comparison of heart function in male and female rats. Basic Res Cardiol. 79:1984;402-412.
77. Pfeffer J.M., Pfeffer M.A., Fletcher P., Fishbein M.C., Braunwald E. Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats. Am J Physiol. 242:(5):1982;H776-H784.
78. Douglas P.S., Katz S.E., Weinberg E.O., et al. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol. 32:(4):1998;1118-1125.
79. Tamura T., Said S., Gerdes A.M. Gender-related differences in myocyte remodeling in progression to heart failure. Hypertension. 33:(2):1999;676-680.
80. Pelzer T., Shamim A., Schumann M., Stimpel M., Wolfges S., Neyses L. Gender specific differences in the hypertrophic response of cardiomyocytes. Circulation. 96(8):1997;1-630. Abstract.
81. Weinberg E.O., Thienelt C.D., Katz S.E., et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol. 34:(1):1999;264-273.
82. Lorell B.H., Weinberg E.O. Gender effects on ace expression during cardiac growth. Circulation. 96(8):1997;1-630. Abstract.
83. O'Rourke M.F. Steady and pulsatile energy losses in the systemic circulation under normal conditions and in simulated arterial disease. Cardiovasc Res. 1:(4):1967;312-326.
84. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:(5789):1980;373-376.
85. Friedman R.J., Moore S., Singal D.P. Repeated endothelial injury and induction of atherosclerosis in normolipemic rabbits by human serum. Lab Invest. 32:(3):1975;404-415.
86. Celermajer D.S., Sorensen K.E., Bull C.M., Robinson J., Deanfield J.E. Endothelium dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 24:1994;468-474.
87. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., et al. Ageing is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 24:1994;471-476.
88. Sarabi M., Millgard J., Lind L. Effects of age, gender and metabolic factors on endothelium-dependent vasodilation: a population-based study. J Intern Med. 246:(3):1999;265-274.
89. Forte P., Kneale B.J., Milne E., et al. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension. 32:(4):1998;730-734.
90. Hashimoto M., Akishita M., Eto M., et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 92:(12):1995;3431-3435.
91. English J.L., Jacobs L.O., Green G., Andrews T.C. Effect of the menstrual cycle on endothelium-dependent vasodilation of the brachial artery in normal young women. Am J Cardiol. 82:(2):1998;256-258.
92. Rosselli M., Imthurm B., Macas E., Keller P.J., Dubey R.K. Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO release. Biochem Biophys Res Commun. 202:(3):1994;1543-1552.
93. Kawano H., Motoyama T., Kugiyama K., et al. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol. 30:(4):1997;914-919.
94. Adams M.R., Robinson J., McCredie R., et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol. 32:(1):1998;123-127.
95. Laogun A.A., Gosling R.G. In vivo arterial compliance in man. Clin Phys Physiol Meas. 3:1982;201-212.
96. Schimmler W. Correlation between the pulse wave velocity in the aorto-iliac vessel and age, sex and blood pressure. Angiology. 17:1966;314-322.
97. London G.M., Guerin A.P., Pannier B., Marchais S.J., Stimpel M. Influence of sex on arterial hemodynamics and blood pressure. Role of body height. Hypertension. 26:1995;514-519.
98. Sonesson B., Hansen F., Stale H., Lanne T. Compliance and diameter in the human abdominal aorta - the influence of age and sex. Eur J Vasc Surg. 7:1993;690-697.
99. de Simone G., Roman M.J., Daniels S.R., et al. Age-related changes in total arterial capacitance from birth to maturity in a normotensive population. Hypertension. 29:(6):1997;1213-1217.
100. London G.M., Guerin A.P., Pannier B.M., Marchais S.J., Metivier F. Body height as a determinant of carotid pulse contour in humans. J Hypertens. 10:(Suppl 6):1992;93-95.
101. Schreiner P.J., Heiss G., Tyroler H.A., et al. Race and gender differences in the association of Lp(a) with carotid artery wall thickness. Arterioscler Thromb Vasc Biol. 16:(3):1996;471-478.
102. Hayward C.S., Kelly R.P. Gender-related differences in the central arterial pressure waveform. J Am Coll Cardiol. 30:(7):1997;1863-1871.
103. Poppas A., Shroff S.G., Korcarz C.E., et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation. 95:(10):1997;2407-2415.
104. Kojda G., Husgen B., Hacker A., et al. Impairment of endothelium-dependent vasorelaxation in experimental atherosclerosis is dependent on gender. Cardiovasc Res. 37:(3):1998;738-747.
105. Holm P., Andersen H.O., Arroe G., Stender S. Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbits. Role of the endothelium and mononuclear-endothelial cell interaction. Circulation. 98:1998;2731-2737.
106. Matsuzaki M., Kobayashi S., Kohno M., et al. Influence of aortic impedance on the development of pressure-overloaded left ventricular hypertrophy in rats. Maruyama Y.H.M, Janicki J.S. Cardiac-vascular remodelling and functional interaction. 1997;203-216 Springer-Verlag, Tokyo.
107. Colditz G.A., Willett W.C., Stampfer M.J., et al. Menopause and the risk of coronary heart disease in women. N Engl J Med. 316:1987;1105-1110.
108. Barrett-Connor E.L., Bush T.L. Estrogen and coronary heart disease in women. J Am Med Assoc. 265:1991;1861-1867.
109. Matthews K.A., Meilahn E., Kuller L.H., et al. Menopause and risk factors for coronary heart disease. N Engl J Med. 312:1989;641-646.
110. Kannel W.B., Hjortland M.C., McNamara P.M. Menopause and risk of cardiovascular disease. The Framingham Study. Ann Int Med. 85:1976;447-452.
111. Akahoshi M., Soda M., Nakashima E., et al. Effects of menopause on trends of serum cholesterol, blood pressure and body mass index. Circulation. 94:1996;61-66.
112. Davis C.E., Pajak A., Rywik S., et al. Natural menopause and cardiovascular disease risk factors: The Poland and US collaborative study on cardiovascular disease epidemiology. Ann Epidemiol. 4-6:1994;445-448.
113. Lindquist O. Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual state: results from a prospective population study of women in Goteberg. Sweden Prev Med. 11:1982;162-172.
114. Staessen J., Bulpitt C., Fagard R., Lijnen R., Amery A. The influence of menopause on blood pressure. J Hum Hypertens. 3:1989;427-433.
115. Owens J.F., Stoney C.M., Matthews K.A. Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation. 88:1993;2794-2802.
116. Pines A., Fisman E.Z., Drory Y., et al. Menopause-induced changes in Doppler derived parameters of aortic flow in healthy women. Am J Cardiol. 69:1992;1104-1106.
117. Pines A., Fisman E.Z., Shemesh J., et al. Menopause-related changes in left ventricular function in healthy women. Cardiology. 80:1992;413-416.
118. Pines A., Fisman E.Z., Levo Y., et al. Menopause-induced changes in left ventricular wall thickness. Am J Cardiol. 72:1993;240-241.
119. Prelevic G.M., Beljic T. The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women. Maturitas. 20:1994;37-44.
120. Karpanou E.A., Vyssoulis G.P., Papakyriakou S.A., Toutouza M.G., Toutouzas P.K. Effects of menopause on aortic root function hypertensive women. J Am Coll Cardiol. 28:1996;1562-1566.
121. Eckstein N., Pines A., Fisman E.Z., et al. The effect of the hypoestrogenic state, induced by gondaotropin-releasing hormone agonist, on Doppler derived parameters of aortic flow. J Clin Endocrinol Metab. 77:1993;910-912.
122. Schaible T.F., Malhotra A., Ciambrone G., Scheuer J. The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res. 54:1984;38-49.
123. Scheuer J., Malhotra A., Schaible T.F., Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res. 61:1987;12-19.
124. Taddei S., Virdis A., Ghiadoni L., et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 28:1996;576-582.
125. Westendorp I.C., Bots M.L., Grobbee D.E., et al. Menopausal status and distensibility of the common carotid artery. Arterioscler Thromb Vasc Biol. 19:(3):1999;713-717.
126. Nabulsi A.A., Folsom A.R., Szklo M. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Circulation. 94:(8):1996;1857-1863.
127. Taquet A., Bonithon-Kopp C., Simon A., et al. Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women. Eur J Epidemiol. 9:(3):1993;298-306.
128. Gangar K.F., Vyas S., Whitehead M., et al. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 338:1991;839-842.
129. Barr D.P., Russ E.M., Ha E. Influence of oestrogen on lipoproteins in atherosclerosis. Transactions of the Association of American Physicians. 65:1952;102-111.
130. Bush T.L., Barrett-Connor E., Cowan L., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 75:1987;1102-1109.
131. Marsh J.D., Lehmann M.H., Ritchie R.H., et al. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation. 98:(3):1998;256-261.
132. Karas R.H., Patterson B.L., Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 89:1994;1943-1950.
133. Mashiah A., Berman V., Thole H.H., et al. Estrogen and progesterone receptors in normal and varicose saphenous veins. Cardiovasc Surg. 7:(3):1999;327-331.
134. Stumpf W.E., Sar M., Aumuller G. The heart: a target organ for estradiol. Science. 196:1977;319-321.
135. McGill H.C., Sheridan P.J. Nuclear uptake of sex steroid hormones in the cardiovascular system of the baboon. Circ Res. 48:1981;238-244.
136. Ingegno M.D., Money S.R., Thelmo W., et al. Progesterone receptors in the human heart and great vessels. Lab Invest. 59:1988;353-356.
137. Klangkalya B., Chan A. The effects of ovarian hormones on beta-adrenergic and muscarinic receptors in rat heart. Life Sci. 42:1988;2307-2314.
138. Baksi S.N., Hughes M.J. Modulation by estradiol of rabbit atrial chronotropic response to histamine. Basic Res Cardiol. 78:1983;505-509.
139. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci. 13:1990;359-362.
140. Aronica S.M., Kraus W.L., Katzenellenbogen B.S. Estrogen action via the cAMP signalling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA. 91:1994;8517-8521.
141. 2+ uptake. Circ Res. 81:(2):1997;242-248.
142. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., et al. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 103:(3):1999;401-406.
143. Mendelsohn M.E., Karas R.H. Estrogen and the blood vessel wall. Curr Opin Cardiol. 9:1994;619-626.
144. Snabes M.C., Payne J.P., Kopelen H.A., et al. Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: a randomized, double-blind, placebo-controlled, crossover trial. Obstet Gynecol. 89:(3):1997;332-339.
145. Kuch B., Hense H.W., Muscholl M., et al. Postmenopausal hormone replacement therapy and left ventricular mass and geometry. J Am Coll Cardiol. 29:1997;297A. Abstract.
146. Lim W.K., Wren B., Jepson N., Roy S., Caplan G. Effect of hormone replacement therapy on left ventricular hypertrophy. Am J Cardiol. 83:(7):1999;1132-1134.
147. Pines A., Fisman E.Z., Levo Y., et al. The effects of hormone replacement therapy in normal postmenopausal women: Measurements of Doppler derived parameters of aortic flow. Am J Obstet Gynecol. 164:1991;806-812.
148. Luotola H., Pyorala T., Lohteehake P., Toivanen J. Haemodynamic and hormonal effects of short-term oestradiol treatment in postmenopausal women. Maturitas. 1:1979;287-294.
149. Slater A.J., Gude N., Clarke I.J., Walters W.A.W. Haemodynamic changes and left ventricular performance during high dose oestrogen administration to male transsexuals. Br J Obstet Gynaecol. 93:1986;532-538.
150. Cabral A.M., Vasquez E.C., Moyses M.R., Antonio A. Sex hormone modulation of ventricular hypertrophy in sino-aortic denervated rats. Hypertension. 11:(2 Pt 2):1988;93-97.
151. Vargas R., Wreblewska B., Rego A., Hatch J., Ramwell P.W. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 109:1993;612-617.
152. Sudhir K., Ling S., Chou T.M., Ives H.E., Chatterjee K. Interactions between estradiol and mechanical strain in human vascular smooth muscle cells in culture. J Am Coll Cardiol. 29:1997;484A. Abstract.
153. Beyer M.E., Yu G., Hoffmeister H.M. Hemodynamic and inotropic effects of estrogen in vivo. Circulation. 94:1996;1-278. Abstract.
154. Raddino R., Manca C., Poli E., Bolognesi R., Visioli O. Effects of 17 β-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn. 281:1986;57-65.
155. Raddino R., Poli E., Pela G., Manca C. Action of steroid sex hormones on the isolated rabbit heart. Pharmacology. 38:(3):1989;185-190.
156. Eckstein N., Nadler E., Barnea O., Shavit G., Ayalon D. Acute effects of 17β-estradiol on the rat heart. Am J Obstet Gynecol. 171:1994;844-848.
157. Jiang C., Poole-Wilson P.A., Sarrel P.M., et al. Effect of 17β-oestradiol on contraction calcium current and intracellular free calcium in guinea pig isolated myocytes. Br J Pharmacol. 106:1992;739-745.
158. Shahar E., Folsom A.R., Salomaa V.V., et al. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Circulation. 93:(11):1996;1970-1975.
159. Koh K.K., Mincemoyer R., Bui M.N., et al. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med. 336:(10):1997;683-690.
160. Chang W.-C., Nakao J., Orimo H., Murota S.-I. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochem Biophys Acta. 620:1980;472-482.
161. Gisclard V., Miller V.M., Vanhoutte P.M. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 244:1988;19-22.
162. Lieberman E.H., Gerhard M.D., Uehata A., et al. Estrogen improves endothelium-dependent, flow mediated vasodilation in postmenopausal women. Ann Intern Med. 121:1994;936-941.
163. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., Cannon R.O. Acute vascular effects of estrogen in postmenopausal women. Circulation. 90:1994;786-791.
164. Keaney J.F., Shwaery C.T., Xu A., et al. 17β-estradiol preserves endothelial vasodilator function and limits low density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 89:1994;2251-2259.
165. McCrohon J.A., Adams M.R., McCredie R.J., et al. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol (Oxf). 45:(4):1996;435-441.
166. White C.R., Shelton J., Chen S.-J., et al. Estrogen restores endothelial cell function in an experimental model of vascular injury. Circulation. 96:(5):1997;1624-1630.
167. Hayashi T., Fukuto J.M., Ignarro L.J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA. 89:1992;11259-11263.
168. Collins P., Rosano G.M.C., Sarrel P.M., et al. 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:1995;24-30.
169. Weiner C.P., Lizasoain I., Baylis S.A., et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
170. Jiang C., Sarrel P.M., Poole-Wilson P.A., Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol. 263:1992;H271-H275.
171. Collins P., Rosano G.M.C., Jiang G., et al. Cardiovascular protection by oestrogen - a calcium antagonist effect. Lancet. 341:1993;1264-1265.
172. Harder D.R., Coulson P.B. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol. 100:1979;375-382.
173. Magness R.R., Rosenfeld C.R. Local and systemic estradiol-17β: effects on uterine and systemic vasodilatation. Am J Physiol. 256:1989;E536-E542.
174. Mugge A., Riedel M., Barton M., Kuhn M., Lichtlen P.R. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc Res. 27:1993;1939-1942.
175. Du X.-J., Riemersma R.A., Dart A.M. Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function. Cardiovasc Res. 30:1995;161-165.
176. Shionoiri H., Eggena P., Barrett J.D., et al. An increase in high molecular weight renin substrate associated with estrogenic hypertension. Biochem Med. 29:1983;14-22.
177. Schunkert H., Danser A.H.J., Hense H.-W., et al. Effects of estrogen replacement therapy on the Renin-Angiotensin System in postmenopausal women. Circulation. 95:1997;39-45.
178. Williams J.K., Adams M.R., Lopfenstein H.S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1990;1680-1687.
179. Williams J.K., Adams M.R., Herrington D.M., Clarkson T.B. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 20:1992;452-457.
180. Williams J.K., Honore E.K., Washburn S.A., Clarkson T.B. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 24:1994;1757-1761.
181. Gilligan D.M., Quyyumi A.A., Cannon R.O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 89:1994;2545-2551.
182. Reis S.E., Gloth S.T., Blumenthal R.S., et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
183. Rosano G.M.C., Sarrel P.M., Poole-Wilson P.A., Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 342:1993;133-136.
184. Webb C.M., Rosano G.M., Collins P. Oestrogen improves exercise-induced myocardial ischaemia in women. Lancet. 351:(9115):1998;1556-1557.
185. Williams J.K., Adams M.R., Clarkson M.R. Effects of oestrogen on vascular tone. J Cardiovasc Pharmacol. 28:(Suppl 5):1996;S29-S33.
186. Gerhard M., Walsh B.W., Tawakol A., et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation. 98:(12):1998;1158-1163.
187. McCrohon J.A., Walters W.A., Robinson J.T., et al. Arterial reactivity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol. 29:(7):1997;1432-1436.
188. New G., Timmins K.L., Duffy S.J., et al. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol. 29:(7):1997;1437-1444.
189. Venkov C.D., Rankin A.B., Vaughan D.E. Identication of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 94:1996;727-733.
190. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 89:1994;1501-1510.
191. Collins P., Sheppard M., Beale C.M., Dowsett M. The classical estrogen receptor is not found in human coronary arteries. Circulation. 92:(8):1995;38-38. Abstract.
192. Iafrati M.D., Karas R.H., Aronovitz M., et al. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat Med. 3:(5):1997;545-548.
193. Manolio T.A., Furberg C.D., Shemanski L., et al. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 88:1993;2163-2171.
194. Selzman C.H., Gaynor J.S., Turner A.S., et al. Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor. Circulation. 98:(19):1998;2049-2054.
195. Fischer G.M. In vivo effects of estradiol on collagen and elastin dynamics in rat aorta. Endocrinology. 91:1972;1227-1232.
196. Wolinsky H. Effects of estrogen and progestogen treatment on the response of the aorta of male rats to hypertension. Morphological and chemical studies. Circ Res. 30:(3):1972;341-349.
197. Hassager C., Jensen L.T., Podenphant J., Riis B.J., Christiansen C. Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones. Metabolism. 39:1990;1167-1169.
198. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J Am Med Assoc. 273:1995;199-208.
199. Miyagawa K., Rosch J., Stanczyk F., Hermsmeyer K. Medroxyprogesterone interferes with ovarian steroid protection against coronary spasm. Nature Med. 3:1997;324-327.
200. Rosano G.M.C., Sarrel P.M., Chierchia S.L., et al. Medroxyprogesterone, but not natural progesterone, reverses the beneficial effect of estradiol 17beta upon exercise-induced myocardial ischemia. Circulation. 94:1996;1-18. Abstract.
201. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc. 280:(7):1998;605-613.
202. Stefanadis C., Tsiamis E., Dernellis J., Toutouzas P. Effect of estrogen on aortic function in postmenopausal women. Am J Physiol. 276:(2 Pt 2):1999;H658-H662.
203. Lehmann E.D., Hopkins K.D., Parker J.R., et al. Aortic distensibility in postmenopausal women receiving Tibolone. Br J Radiol. 67:1994;701-705.
204. Giraud G.D., Morton M.J., Wilson R.A., Burry K.A., Speroff L. Effects of estrogen and progestin on aortic size and compliance in postmenopausal women. Am J Obstet Gynecol. 174:1996;1708-1718.
205. Rajkumar C., Kingwell B.A., Cameron J.D., et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol. 30:(2):1997;350-356.
206. Hayward C.S., Knight D.C., Wren B.G., Kelly R.P. Effect of hormone replacement therapy on noninvasive cardiovascular haemodynamics. J Hypertension. 15:1997;987-993.
207. Kovacs L., Bartfai G., Apro G., et al. The effect of the contraceptive pill on blood pressure: a randomised controlled trial of three progesterone-oestrogen combinations in Szeged, Hungary. Contraception. 33:1986;69-77.
208. Chasan-Taber L., Willett W.C., Manson J.E., et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation. 94:1996;483-489.
209. Mashchak C.A., Lobo R.A. Estrogenic replacement therapy and hypertension. J Reprod Med. 30:(10):1985;805-810.
210. Lip G.Y.H., Beevers M., Churchill D., Beevers D.G. Hormone replacement therapy and blood pressure in hypertensive women. J Human Hypert. 8:1994;491-494.
211. Lind T., Cameron E.C., Hunter W.M., et al. A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol. 86:(Suppl 3):1979;1-30.
212. Hammond C.B., Jelovsek F.R., Lee K.L., Creasman W.T., Parker R.T. Effects of long term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol. 133:1979;525-536.
213. Conard J., Basdevant A., Thomas J.-L., et al. Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with noegestrol acetate and estradiol. Fertil and Steril. 64:1995;957-962.
214. Khoo S.-K., Coglan M.J., Wright G.R., DeVoss K.N., Battistutta D. Hormone therapy in women in the menopause transition. Randomised, double blind, placebo controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium. Med J Aust. 168:1998;216-220.
215. Crane M.G., Harris J.J., Winsor III W. Hypertension, oral contraceptive agents and conjugated estrogens. Ann Intern Med. 74:1971;13-21.
216. Notelovitz M. Effect of natural oestrogens on blood pressure and weight in postmenopausal women. S Afr Med J. 49:1975;2251-2254.
217. Utian W.H. Effect of postmenopausal estrogen therapy on diastolic blood pressure and weight. Maturitas. 1:1978;3-8.
218. Wren B.G., Routledge A.D. The effect of type and dose of oestrogen on the blood pressure of postmenopausal women. Maturitas. 5:1983;135-142.
219. Luotola H. Blood pressure and hemodynamics in postmenopausal women during estradiol-17β substitution. Ann Clin Res. 15:(Suppl 38):1983;9-112.
220. Rosano G.M.C., Sposato B., Leonardo F., et al. Chronic transdermal 17β-oestradiol therapy lowers blood pressure in newly diagnosed hypertensive postmenopausal women. Eur Heart J. 20:(Suppl):1999;544. Abstract.
221. Jespersen C.M., Arnung K., Hagen C., et al. Effects of natural oestrogen therapy on blood pressure and renin angiotensin system in normotensive and hypertensive menopausal women. J Hypertension. 1:1983;361-364.
222. Hoeg J.M., Willis I.R., Weinberger M.H. Estrogen attenuation of the development of hypertension in spontaneously hypertensive rats. Am J Physiol. 233:(3):1977;H369-H373.
223. Sullivan M.L., Martinez C.M., Gennis P., Gallagher E.J. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 41:(1):1998;1-15.
224. Somjen D., Kohen F., Jaffe A., et al. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension. 32:(1):1998;39-45.
225. Hurley B.F., Seals D.R., Hagberg J.M., et al. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use. J Am Med Assoc. 252:(4):1984;507-513.
226. Uyanik B.S., Ari Z., Gumus B., Yigitoglu M.R., Arslan T. Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study. Jpn Heart J. 38:(1):1997;73-82.
227. McCredie R.J., McCrohon J.A., Turner L., et al. Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol. 32:(5):1998;1331-1335.
228. Ong P.J.L., Patrizi G., Chong W.C.F., et al. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. Am J Cardiol. 85:2000;14-17.
229. Khaw K.T., Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arterioscler Thromb. 11:(3):1991;489-494.
230. Zmuda J.M., Cauley J.A., Kriska A., et al. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol. 146:(8):1997;609-617.
231. Barrett-Connor E.L., Khaw K.T., Yen S.S. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 315:1986;1519-1524.
232. Phillips G.B., Pinkernell B.H., Jing T.Y. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 14:(5):1994;701-706.
233. Duell P.B., Bierman E.L. The relationship between sex hormones and high-density lipoprotein cholesterol levels in healthy adult men. Arch Intern Med. 150:(11):1990;2317-2320.
234. Barrett-Connor E., Khaw K.T. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation. 78:(3):1988;539-545.
235. Haffner S.M., Mykkanen L., Valdez R.A., Katz M.S. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J Clin Endocrinol Metab. 77:(6):1993;1610-1615.
236. Adams M.R., Williams J.K., Kaplan J.R. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol. 15:(5):1995;562-570.
237. Barrett-Connor E., Khaw K.T. Absence of an inverse relation of dehydroepiandrosterone sulfate with cardiovascular mortality in postmenopausal women [letter]. N Engl J Med. 317:(11):1987;711.
238. Birdsall M.A., Farquhar C.M., White H.D. Association between polycystic ovaries and extent of coronary disease in women having cardiac catheterisation. Ann Intern Med. 126:(1):1997;32-35.
239. Bruck B., Brehme U., Gugel N., et al. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc biol. 17:1997;2192-2199.
240. Ebeling P., Koivisto V.A. Physiological importance of dehydroepiandrosterone. Lancet. 343:(8911):1994;1479-1481.
241. Lengsfeld M., Morano I., Ganten U., Ganten D., Ruegg J.C. Gonadectomy and hormonal replacement changes systolic blood pressure and ventricular myosin isoenzyme pattern of spontaneously hypertensive rats. Circ Res. 63:(6):1988;1090-1094.
242. Morano I., Gerstner J., Ruegg J.C., et al. Regulation of myosin heavy chain expression in the hearts of hypertensive rats by testosterone. Circ Res. 66:(6):1990;1585-1590.
243. 2+ activated tension development in single adult cardiac myocytes. Circ Res. 84:(11):1999;1310-1317.
244. Malhotra A., Buttrick P., Scheuer J. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol. 259:(3 Pt 2):1990;H866-H871.
245. Urhausen A., Holpes R., Kindermann W. One- and two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol. 58:(6):1989;633-640.
246. Trifunovic B., Norton G.R., Duffield M.J., Avraam P., Woodiwiss A.J. An androgenic steroid decreases left ventricular compliance in rats. Am J Physiol. 268:(3 Pt 2):1995;H1096-H1105.
247. Wichmann M.W., Zellweger R., DeMaso C.M., Ayala A., Chaudry I.H. Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine. 8:(11):1996;853-863.
248. Remmers D.E., Wang P., Cioffi W.G., Bland K.I., Chaudry I.H. Testosterone receptor blockade after trauma-hemorrhage improves cardiac and hepatic functions in males. Am J Physiol. 273:(6 Pt 2):1997;H2919-H2925.
249. Alexandersen P., Haarbo J., Byrjalsen I., Lawaetz H., Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res. 84:(7):1999;813-819.
250. Herman S.M., Robinson J.T.C., McCredie R.J., et al. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscl Thromb Vasc Biol. 17:1997;2004-2009.
251. Rosano G.M., Leonardo F., Pagnotta P., et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation. 99:(13):1999;1666-1670.
252. Webb C.M., Adamson D.L., de Zeigler D., Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol. 83:(3):1999;437-439.
253. Chou T.M., Sudhir K., Hutchison S.J., et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 94:(10):1996;2614-2619.
254. Yue P., Chatterjee K., Beale C., Poole-Wilson P.A., Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 91:(4):1995;1154-1160.
255. Webb C.M., McNeill J.G., Hayward C.S., de Zeigler D., Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary artery disease. Circulation. 100:1999;1690-1696.
256. Ceballos G., Figueroa L., Rubio I., et al. Acute and nongenomic effects of testosterone on isolated and perfused rat heart. J Cardiovasc Pharmacol. 33:(5):1999;691-697.